188 related articles for article (PubMed ID: 30415992)
1. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis.
Sand FL; Nielsen DMB; Frederiksen MH; Rasmussen CL; Kjaer SK
Gynecol Oncol; 2019 Jan; 152(1):208-217. PubMed ID: 30415992
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
[TBL] [Abstract][Full Text] [Related]
3. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
[TBL] [Abstract][Full Text] [Related]
4. TP53 mutation and human papilloma virus status as independent prognostic factors in a Norwegian cohort of vulva squamous cell carcinoma.
Dongre HN; Elnour R; Tornaas S; Fromreide S; Thomsen LCV; Kolseth IBM; Nginamau ES; Johannessen AC; Vintermyr OK; Costea DE; Bjørge L
Acta Obstet Gynecol Scand; 2024 Jan; 103(1):165-175. PubMed ID: 37840151
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.
Carreras-Dieguez N; Saco A; Del Pino M; Marimon L; López Del Campo R; Manzotti C; Fusté P; Pumarola C; Torné A; Garcia A; Rakislova N
Histopathology; 2023 Jul; 83(1):17-30. PubMed ID: 37099408
[TBL] [Abstract][Full Text] [Related]
6. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
7. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
8. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation.
Dohopolski MJ; Horne ZD; Pradhan D; Bhargava R; Edwards RP; Kelley JL; Comerci JT; Olawaiye AB; Courtney-Brooks M; Berger JL; Sukumvanich P; Beriwal S
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):152-160. PubMed ID: 30121234
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy.
Yap ML; Allo G; Cuartero J; Pintilie M; Kamel-Reid S; Murphy J; Mackay H; Clarke B; Fyles A; Milosevic M
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):254-261. PubMed ID: 29449057
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study.
McAlpine JN; Leung SCY; Cheng A; Miller D; Talhouk A; Gilks CB; Karnezis AN
Histopathology; 2017 Aug; 71(2):238-246. PubMed ID: 28257152
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
[TBL] [Abstract][Full Text] [Related]
13. High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining.
Höhn AK; Forberger M; Alfaraidi M; Gilks CB; Brambs CE; Höckel M; Hoang L; Singh N; Horn LC
Gynecol Oncol; 2024 Jun; 185():17-24. PubMed ID: 38342005
[TBL] [Abstract][Full Text] [Related]
14. p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases.
Cheng AS; Karnezis AN; Jordan S; Singh N; McAlpine JN; Gilks CB
Int J Gynecol Pathol; 2016 Jul; 35(4):385-93. PubMed ID: 26630231
[TBL] [Abstract][Full Text] [Related]
15. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Significance of HPV and p16 Status in Men Diagnosed with Penile Cancer: A Systematic Review and Meta-analysis.
Sand FL; Rasmussen CL; Frederiksen MH; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1123-1132. PubMed ID: 29987099
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: A systematic review.
Rasmussen CL; Bertoli HK; Sand FL; Kjaer AK; Thomsen LT; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2144-2156. PubMed ID: 34546565
[TBL] [Abstract][Full Text] [Related]
18.
Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of high-risk human papillomavirus DNA and p16
Obermueller T; Hautekiet J; Busto MP; Reynders D; Belgioia L; Cats A; Gilbert DC; Koerber SA; Mai S; Meulendijks D; Rödel F; Yhim HY; Hetjens S; Weiß C; Rasmussen CL; Urbute A; Verdoodt F; Kjaer SK; Reuschenbach M; Goetghebeur E; von Knebel Doeberitz M; Arbyn M; Prigge ES
Eur J Cancer; 2021 Nov; 157():165-178. PubMed ID: 34517306
[TBL] [Abstract][Full Text] [Related]
20. Does HPV status influence survival after vulvar cancer?
Rasmussen CL; Sand FL; Hoffmann Frederiksen M; Kaae Andersen K; Kjaer SK
Int J Cancer; 2018 Mar; 142(6):1158-1165. PubMed ID: 29090456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
